Trends in cost of treatment of lung cancer patients in 2014-2019 in Finland - a descriptive register study.

Riikka-Leena LeskeläSonja KorhonenIra HaavistoMikko NuutinenEmmi PeltonenFredrik HerseSari KäkeläAnna-Maija AutereKatja NolviSatu TiainenMaria SilvoniemiEeva-Liisa JunnilaJarkko AhvonenAija KnuuttilaJussi Koivunen

Published in: Acta oncologica (Stockholm, Sweden) (2023)

The average cost per patient has increased annually for both NSCLC and SCLC. Possible explanations to the cost increase are increased medicine costs (especially in NSCLC), and the increased percentage of patients being actively treated.

Keyphrases

end stage renal disease
newly diagnosed
small cell lung cancer
ejection fraction
peritoneal dialysis
advanced non small cell lung cancer
cross sectional
case report
combination therapy
replacement therapy
epidermal growth factor receptor
patient reported